J. Krisl

发表

Off‐Label Use of Immunosuppressive Agents in Solid Organ Transplantation

R. Alloway, E. Woodle, J. Krisl, 2014 .

Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation

W. Suki, A. Frost, A. Bhimaraj, 2021, ASAIO journal.

Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft Survival

R. Alloway, E. Woodle, A. Girnita, 2015, Transplantation.

Remote versus early corticosteroid wean outcomes in heart transplant recipients in the contemporary era

E. Graviss, A. Bhimaraj, G. Torre-Amione, 2021, Clinical transplantation.

Clinical Usefulness of Recombinant Activated Factor VII in Patients with Liver Failure Undergoing Invasive Procedures

J. Mazur, C. Greenberg, J. Krisl, 2011, The Annals of pharmacotherapy.

Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients

J. Krisl, V. Doan, J. C. Krisl, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of an Intracranial Pressure Monitor

J. Mazur, C. Greenberg, H. Meadows, 2011, The Annals of pharmacotherapy.

Role of thromboelastography in predicting and defining pump thrombosis in left ventricular assist device patients.

E. Graviss, A. Guha, D. Nguyen, 2020, Thrombosis research.

Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities

Kevin R. Donahue, J. Krisl, S. Varnado, 2018, ASAIO journal.

Disruptions in the Supply of Medications Used in Transplantation: Implications and Management Strategies for the Transplant Clinician

D. Taber, C. Fortier, J. Krisl, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Descriptive analysis evaluating the use of direct oral anticoagulation therapy in heart and lung transplant recipients

Kevin R. Donahue, J. Krisl, M. Cooper, 2022, Clinical transplantation.

Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.

C. Bratton, K. Chavin, P. Baliga, 2012, Clinical journal of the American Society of Nephrology : CJASN.

A Case‐Based Approach to the Practical Application of Dexmedetomidine in Critically Ill Adults

R. MacLaren, S. Mueller, J. Krisl, 2013, Pharmacotherapy.

Heart or lung transplant outcomes in HIV-infected recipients.

M. Hannan, N. Mueller, P. Grossi, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.

R. Alloway, E. Woodle, A. Shields, 2014, Transplantation.